DJS Antibodies
Joe Illingworth is a co-founder and serves as the Director of Research and Chief Scientific Officer at DJS Antibodies, a biotech start-up focused on developing therapeutic monoclonal antibodies for challenging targets, including membrane proteins, since February 2014. Prior experience includes serving as a PhD student at the Jenner Institute, University of Oxford from October 2010 to October 2014, and as an Amgen Scholar at Karolinska Institutet in June 2009. Joe Illingworth earned a Doctor of Philosophy (Ph.D.) in Infection, Immunology and Translational Medicine from the University of Oxford and a Bachelor of Science (BSc) in Biochemistry from Imperial College London.
This person is not in any teams
DJS Antibodies
1 followers
DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. The company's breakthrough technology enables its to produce first-in-class antibody therapeutics to previously intractable disease targets.